Results 131 to 140 of about 4,691 (166)

Staphylococcus aureus Panton-Valentine Leukocidin worsens acute implant-associated osteomyelitis in humanized BRGSF mice. [PDF]

open access: yesJBMR Plus
Hofstee MI   +12 more
europepmc   +1 more source

Panton-Valentine leukocidin (PVL)

open access: yesPanton-Valentine leukocidin (PVL)
openaire  

Pragmatic management of Panton–Valentine leukocidin-associated staphylococcal diseases

open access: yesInternational Journal of Antimicrobial Agents, 2011
Panton-Valentine leukocidin (PVL)-producing Staphylococcus aureus is associated with a broad spectrum of diseases, ranging from common uncomplicated soft tissue infections to severe diseases such as complicated soft tissue infections, extensive bone and joint infections, and necrotising pneumonia.
Oana Dumitrescu   +2 more
exaly   +4 more sources

MALDI-TOF-MS for rapid detection of staphylococcal Panton–Valentine leukocidin [PDF]

open access: yesInternational Journal of Antimicrobial Agents, 2009
Toxin-producing gram-positive bacteria are responsible for emerging and life-threatening infections in humans worldwide. Both rapid toxin detection and adapted therapy are essential to limit the morbidity due to such toxins, especially staphylococcal Panton-Valentine leukocidin (PVL). Here we describe the use of a mass spectrometry profile generated by
Didier Raoult   +2 more
exaly   +5 more sources

A latex agglutination assay for specific detection of Panton–Valentine leukocidin

Journal of Microbiological Methods, 2008
Panton-Valentine leukocidin (PVL) is produced by some isolates of Staphylococcus aureus, and has been associated with the high pathogenic potential of these strains. To rapidly detect the toxin producer strains, we developed a reverse passive latex agglutination (RPLA) reaction assay specific for PVL. By testing 64 S.
Takamichi Itô, Tadashi Baba
exaly   +3 more sources

Panton-Valentine leukocidin: raising practitioner awareness

British Journal of Community Nursing, 2007
Media reports have focused recently on methicillin resistant Staphylococcus aureus (MRSA). Panton-Valentine leukocidin is a toxin carried by MRSA. With reported increases in community acquired MRSA, This article seeks to raise practitioner awareness of this toxin and it’s effects on dermal tissue. A case study and anecdotal evidence is given.
Michelle, Beer, Mair, Fear
openaire   +2 more sources

Panton-Valentine leukocidin-positive osteoarticular infections

Médecine et Santé Tropicales, 2015
The aim of our study was to evaluate the frequency of osteoarticular infections with Panton-Valentine leukocidin-positive (PVL) Staphylococcus aureus (PVL-SA) among patients admitted to the orthopedic ward at the Sahloul University Hospital (Sousse, Tunisia) and to study the characteristics of these strains and patients.We conducted a retrospective ...
C, Chaouch   +5 more
openaire   +2 more sources

Staphylococcal Leukocidin, Panton-Valentine Type

Journal of Toxicology: Toxin Reviews, 1985
AbstractThe Panton-Valentine leukocidin produced by most strains of S. aureus attacks polymorphonuclear leukocytes and macrophages but not other cell types. The toxin, discovered by van de Velde in 1894, was distinguished clearly from leukocyte-damaging hemolysins by the studies of Panton and Valentine. Purified for the first time by Woodin in 1960, it
Piotr L. Grójec, Janusz Jeljaszewicz
openaire   +1 more source

Gene sequences and specific detection for Panton-Valentine leukocidin

Biochemical and Biophysical Research Communications, 2005
A new category of methicillin-resistant Staphylococcus aureus (MRSA), called community-acquired MRSA (CA-MRSA), has emerged worldwide. In contrast to previous MRSA, most CA-MRSA carries the Panton-Valentine leukocidin (PVL) genes (lukPVSF) as a virulence genetic trait.
Saori, Nakagawa   +8 more
openaire   +2 more sources

Necrotising Pneumonia, Staphylococcus Aureus and Panton-Valentine Leukocidin

Journal of the Intensive Care Society, 2008
The Panton-Valentin leukocidin (PVL) strain of meticillin-resistant Staphylococcus aureus (MRSA) is producing a new pattern of MRSA-related disease in the UK and world-wide. PVL is one of several extracellular cytotoxins produced by Staphylococcus aureus, and is usually associated with skin and soft tissue infections. PVL MRSA is uncommon in hospitals,
Brendan Mcgrath
exaly   +2 more sources

Home - About - Disclaimer - Privacy